Inhibitor of apoptosis (IAP) proteins suppress apoptosis and inhibit caspases. Several IAPs also function as ubiquitinprotein ligases. Regulators of IAP auto-ubiquitination, and thus IAP levels, have yet to be identified. Here we show that Head involution defective (Hid), Reaper (Rpr) and Grim downregulate Drosophila melanogaster IAP1 (DIAP) protein levels. Hid stimulates DIAP1 polyubiquitination and degradation. In contrast to Hid, Rpr and Grim can downregulate DIAP1 through mechanisms that do not require DIAP1 function as a ubiquitin-protein ligase. Observations with Grim suggest that one mechanism by which these proteins produce a relative decrease in DIAP1 levels is to promote a general suppression of protein translation. These observations define two mechanisms through which DIAP1 ubiquitination controls cell death: first, increased ubiquitination promotes degradation directly; second, a decrease in global protein synthesis results in a differential loss of short-lived proteins such as DIAP1. Because loss of DIAP1 is sufficient to promote caspase activation, these mechanisms should promote apoptosis.
A
poptosis is an evolutionarily conserved process through which organisms eliminate damaged or unwanted cells (reviewed in refs 1,2). Members of the caspase protease family are central components of the machinery that carries out this process 3, 4 . Most, if not all, cells express caspases sufficient to carry out apoptosis 5 . Because proteolysis is irreversible and caspases can amplify cascades of proteolysis, caspase activation and activity must be tightly regulated. The only known cellular caspase inhibitors are members of the IAP family 6, 7 . Many death-inhibiting IAPs have a carboxy-terminal RING domain. In many proteins, including several IAPs, this domain is necessary, and sometimes sufficient, to mediate E3 ubiquitin-protein ligase activity, catalysing the transfer of ubiquitin to E3-bound substrates 8 . This activity can promote auto-ubiquitination and subsequent IAP degradation, which presumably promotes apoptosis 9 . It can also promote the ubiquitination of bound caspases, presumably resulting in the inhibition of apoptosis 10, 11 . One important question is how IAP E3 activity is regulated. Evidence that such regulation is important comes from the observation in thymocytes that some death stimuli result in a decrease in IAP protein levels through a pathway that requires IAPs to be functional as E3s 9 . These observations suggest the existence of molecules that promote cell death by stimulating IAP ubiquitination. The Drosophila apoptosis inducer and IAPinteracting protein Hid is an interesting candidate because versions of DIAP1 that lack an intact RING domain are better able to protect against Hid-dependent death than wild-type versions 12, 13 . In fact, we show here that expression of Hid results in a dramatic decrease in DIAP1 levels in vivo, and that this is associated with a corresponding increase in caspase activation. This activity requires DIAP1 ubiquitin-protein ligase activity, and in vitro assays demonstrate that Hid directly promotes DIAP1 ubiquitination and degradation. Expression of two other Drosophila apoptosis inducers, Rpr and Grim, also result in the in vivo loss of DIAP1. Interestingly, this activity does not require the ubiquitin-protein ligase function of DIAP1, indicating that these proteins can regulate DIAP1 levels through a different mechanism. The in vitro observations with Grim described here, and with Rpr by Holley et al. (see note added in proof), show that these proteins can suppress general protein translation. Finally, we show that DIAP1 has a short half-life, whereas the half-life of the DIAP1-inhibitable apical caspase, Dronc, is much longer, and that loss of DIAP1 is sufficient to activate effector caspases. Together, these observations define two mechanisms through which IAP protein levels can be reduced in relation to the levels of apoptosis inducers.
Results
To characterize the relationship between IAP function and caspase activation in vivo, we generated an antibody that recognizes cleaved, and therefore active, versions of the effector caspase Drice 14 . This antibody specifically recognized dying cells. Labelling was present in many cells throughout the Drosophila wild-type stage 14 embryo (Fig. 1a) , but was essentially absent from embryos homozygous for a chromosomal deletion (H99), which do not undergo normally occuring cell death 15 ( Fig. 1b) . Anti-active Drice labelling ( Fig. 1d ) also correlated well with labelling of DNA fragmentation (Fig. 1c) , which requires caspase activation in Drosophila 16, 17 . DIAP1 functions in the early embryo to inhibit caspase activity. DIAP1 inhibits the activity of multiple Drosophila caspases [18] [19] [20] [21] and is required for the survival of many cells in the fly 12, 13, 19, 22 . Loss of DIAP1 in the embryo is associated with a large increase in DEVDase caspase activity, but in which cells caspase activation occurs is unknown 19 . We stained embryos that were homozygous for a loss-of-function allele of DIAP1, th109, with anti-active Drice f focus on apoptosis (refs 13,23) . Essentially all cells contained activated Drice (Fig 1f,h) . Initially, embryos could be identified that stained for active Drice (Fig. 1f) , but lacked significant DNA fragmentation, as visualized with TUNEL staining (Fig 1e) . Ultimately, however, cells became reactive to both probes (Fig. 1g,h ). We also generated homozygous mutant DIAP1 embryos, in which the baculovirus caspase inhibitor p35 was ubiquitously expressed during early embryogenesis (Fig. 1j) . In these embryos, Drice activation still occurred throughout the embryo at the extended germ-band stage (stage 10; Fig. 1l ). However, through stage 11, DNA fragmentation was always largely absent (Fig. 1i,k) . In addition, although embryos homozygous for amorphic DIAP1 alleles undergo morphogenetic arrest during germ-band extension (stage 8) 19 , DIAP1 mutant embryos that expressed p35 underwent normal morphogenesis until stage 11 (Fig. 1i,k) . After this time, maternal p35 was lost and massive cell death resumed (data not shown). Together, these observations make several points: first, loss of DIAP1 in the early embryo results in effector caspase activation in most, if not all, cells, and this activity is required for nuclease activation. Second, Drice activation is itself largely insensitive to the presence of p35. Third, . These embryos also express lacZ under the control of the ftz promoter. Anti-β-galactosidase staining is shown in blue. d, The embryo in c stained with anti-active Drice (red). e, A homozygous th109 embryo at stage 8 stained for TUNEL (green). f, The embryo in e stained for active Drice (red). g, A th109 embryo at stage 10 stained for TUNEL (green). h, The embryo in g stained for active Drice (red). i, TUNEL staining of a stage-10 embryo with genotype mat67G4/mat67G4; mat15G4, th5/th5, UAS::p35. This embryo is mutant for DIAP1, but survives because of p35 expression. j, The embryo in i stained for p35. k, An embryo with the same genotype as j at stage 11 stained for TUNEL. l, The embryo in j stained with anti-active Drice. Anti-active Drice antibodies specifically recognize dying cells (a,b). Anti-active Drice labelling (d) shows good correspondence with TUNEL staining (c). Drice (f) becomes activated before TUNEL labelling appears (e). Ubiquitous expression of p35 (j) rescues stage-10 (i) and -11 (k) embryos from cell death, as indicated by the essential lack of TUNEL labelling (green). However, ubiquitous expression of p35 does not prevent the activation of Drice (l). Confocal images of wing discs from third-instar larvae of various genotypes. Posterior is to the right. a, Wing disc from a third instar larvae of genotype UAS::Hid, UAS::p35; engrailed Gal4 (en::Gal4), stained with anti-Hid (green). b, Wing disc in a larvae stained with anti-p35 (red). c, Merge of a and b. d, Wing disc of a larvae with genotype UAS::p35; en::Gal4 stained with anti-DIAP1 (red). e, A UASp35; enGal4 wing disc stained for TUNEL (green). f, A UAS::Hid, UAS::p35; en::Gal4 wing disc stained for TUNEL (green). g, A UAS::Hid, UAS::p35; en::Gal4 wing disc stained with anti-active Drice (green). h, The wing disc in g stained with anti-DIAP1 (red). i, merge of g and h. j, A wing disc of genotype UAS::Rpr, UAS::p35; en::Gal4 stained with anti-active Drice (green). k, The wing disc in j stained with anti-DIAP1 (red). l, Merge of j and k. The engrailed promoter drives expression of Hid and p35 in the posterior wing compartment (a-c). In the presence of engrailed-driven p35, DIAP1 is expressed uniformly throughout the wing disc (d). Levels of TUNEL labelling in wing discs expressing Hid and p35 (f) are similar to those of discs expressing p35 alone (e). This, as well as the fact that Hidexpressing wing discs are morphologically normal, despite the fact that they have been expressing Hid for quite some time, argues that p35 effectively suppresses Hid-dependent effector caspase activity. Expression of Hid under engrailed control results in Drice activation in the posterior wing compartment (g). This is associated with a corresponding decrease in DIAP1 in these same cells (h,i). Expression of rpr under control of the engrailed promoter also results in Drice activation in the posterior wing compartment (j). This is also associated with a corresponding decrease in DIAP1 levels (k,l).
as Drice requires cleavage by other proteases for activation, loss of DIAP1 probably initially results in the activation of a p35-insensitive protease. Fourth, Dronc, a DIAP1-inhibitable, but p35-insensitive, caspase implicated in multiple death pathways, is a good candidate for such an activator 20, 21, 24, 25 . Consistent with this possibility, removal of Dronc in S2 cells through RNA interference prevented cell death induced by downregulation of DIAP1 (I.M. and R.J.C., manuscript submitted). Finally, the fact that DIAP1 mutant embryos rescued from death by p35 expression continued morphologically normallooking development for several more hours is consistent with the hypothesis that the primary anti-apoptotic function of DIAP1, at least during early embryonic development, is to inhibit caspase activity. Hid, Rpr and Grim downregulate DIAP1 in vivo through distinct, post-transcriptional mechanisms. Because loss of DIAP1 is sufficient to promote cell-death-inducing caspase activity in many cells, it is important to understand how its activity is regulated. Rpr, Hid and Grim are essential apoptosis inducers in Drosophila
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. One mechanism through which they function involves binding to DIAP1, thereby directly suppressing its ability to inhibit caspase activity 19, 22, 27 . A number of observations argue that these proteins also have other pro-apoptotic activities, but the relationship of these activities to the regulation of DIAP1 function is unknown 22, 28, 29, 30, 31, 32 . The control of IAP stability has recently emerged as an interesting possibility, based on the twin observations that IAPs can undergo auto-ubiquitination, thus promoting their own degradation, and that some death stimuli result in an increase in IAP ubiquitination 9 . Genetic evidence argues that Hid has a greater ability to promote apoptosis in the presence of wildtype DIAP1 than in the presence of RING mutated forms, consistent with the possibility that Hid promotes death by stimulating DIAP1 auto-ubiquitination and degradation 12, 13 . To examine this possibility directly, we characterized wing discs expressing Hid and p35 in the posterior wing compartment, under the control of the engrailed promoter (Fig. 2a,b, respectively; Fig. 2c, merge) . Coexpression of Hid and p35 resulted in the activation of Drice in the posterior wing compartment (Fig. 2g) . These cells showed a dramatic downregulation of DIAP1 levels (Fig. 2h,i) . Importantly, this was not associated with an increase in Drice activity, as demonstrated by the fact that wing discs expressing Hid and p35 showed low levels of DNA fragmentation (Fig. 2f ), similar to those of wing discs expressing p35 alone (Fig. 2e ).
We also examined wing discs expressing Rpr and p35 under control of the engrailed promoter. Drice became activated in the posterior wing compartment (Fig. 2j) , and this was also associated with a dramatic loss of DIAP1 protein levels ( Fig. 2k,l) . Larvae expressing Grim and p35 under the control of the engrailed promoter do not survive through late third-instar larval stages. Therefore we analysed the effects of Grim on DIAP1 levels in embryos. As in the wing disc, co-expression of Hid and p35 under the control of the engrailed promoter resulted in a loss of DIAP1 in the cells that expressed Hid (Fig.3 a,b ; compare to 3c). Similar results were obtained when Grim or Rpr was co-expressed with p35 ( Fig. 3d ,e, respectively). DIAP1 levels were dramatically lowered in a segmentally repeated pattern corresponding to the domain of engrailed expression. In both the wing disc and the embryo, expression of Rpr or Grim resulted in a greater decrease in DIAP1 levels than did expression of Hid (Figs 2,3 ). These differences may simply reflect differences in the strength of transgene expression. Alternatively, they may point towards differences in the mechanisms by which Hid, Rpr and Grim promote loss of DIAP1, or mechanisms by which their ability to mediate this loss is regulated.
To determine if expression of Hid, Rpr, or Grim was downregulating DIAP1 transcript levels, we examined DIAP1 expression levels in embryos of various genotypes. DIAP1 was ubiquitously expressed in wild-type embryos, probably in all cells (data not shown). However, superimposed on this general pattern were domains in which levels of the DIAP1 transcript were increased. These could be observed when in situ hybridizations were developed for a very short period of time (Fig. 4) . At stage 10 ( Fig. 4d) , segmental modulation of DIAP1 is apparent. This repeated pattern overlaps with the parasegmental boundaries (Fig. 4f ,h,j,l; arrows) and with the domains of engrailed expression (Fig. 4e ,g,i,k) Importantly, levels of the DIAP1 transcript within the engrailed domain, in which Hid, Rpr or Grim were expressed, were similar in wild-type (Fig. 4e,f) , Hid-expressing (Fig. 4g,h ), Grim-expressing (Fig. 4i,j) or Rpr-expressing (Fig. 4k,l) embryos. These observations do not rule out the possibility that Hid, Rpr, or Grim function as transcriptional regulators in some contexts. However, they do suggest that transcriptional downregulation of DIAP1 is not a dominant mechanism to promote the loss of DIAP1 protein.
Together, these observations demonstrate that expression of Hid, Rpr or Grim results in a post-transcriptional loss of DIAP1. The th6 mutant form of DIAP1 alters an essential cysteine residue in the DIAP1 RING domain 13 and results in a lack of E3 activity (Fig. 6b) . To test whether the ability of Hid, Rpr, and Grim to reduce DIAP1 levels requires DIAP1 ubiquitin-protein ligase activity, we analysed the fate of the th6 protein in tissues that expressed p35 and one of these proteins. th6 homozygotes die during embryogenesis. Wild-type DIAP1 has a robust auto-ubiquitination activity and a short half-life of about 42 min (see Supplementary  Information, Fig. S1 ). Thus, we reasoned that much of the DIAP1 protein present in th6 heterozygotes was of the mutant form, as it lacked the ability of wild-type DIAP1 to undergo auto-ubiquitination. Wing discs from th6 heterozygotes that expressed p35 and Rpr or Hid under the control of the engrailed promoter showed strong Drice activation in the posterior wing compartment (Fig. 5a,d ). In the case of Rpr-expressing discs, this was associated with a strong decrease in DIAP1 protein levels (Fig. 5b) . In contrast, there was no appreciable difference in DIAP1 levels between the anterior and posterior wing compartments in Hid-expressing wing discs from th6 heterozygotes (Fig. 5e) . Heterozygosity for th6 did not appreciably diminish the ability of Grim to promote the disappearance of DIAP1 in the embryo (data not shown). Based on these observations, we conclude that Hid, but not Rpr and Grim, promotes the loss of DIAP1 through a mechanism that requires an intact RING domain. Hid stimulates DIAP1 polyubiquitination. We introduced DIAP1 into a ubiquitination assay containing E1, E2 (Ubc5) and ubiquitin, and characterized the DIAP1 products by western blotting with an anti-DIAP1 antibody. DIAP1 was shifted into a ladder of high molecular weight species in a time-dependent manner (Fig. 6a) . DIAP1 was similarly upshifted in the presence of Drosophila embryo extract containing the proteosome inhibitor lactacystin (Fig. 6b) . In contrast, th6 DIAP1 remained unchanged when incubated in the same system (Fig. 6b) . Thus, DIAP1 has E3 ubiquitinprotein ligase activity, resulting in auto-ubiquitination, and this requires an intact DIAP1 RING domain. The failure of th6 DIAP1 to be modified in the presence of embryo extract is consistent with, but does not prove, that in this more complex system, the laddering seen with wild-type DIAP1 was the result of auto-ubiquitination rather than ubiquitination by some other ligase. Addition of recombinant Rpr and Grim to this reaction did not result in an appreciable stimulation of DIAP1 polyubiquitination (Fig. 6c) . In contrast, addition of Hid resulted in a marked stimulation of DIAP1 polyubiquitination, as indicated by the increase in high molecular weight DIAP1 bands at 10 and 30 min (Fig. 6d) . Importantly, however, though Hid bound th6 DIAP1 as well as wildtype DIAP1 (Fig. 7c) , it was unable to stimulate th6 DIAP1 polyubiquitination (Fig. 6e) . This suggests that Hid promotes DIAP1 auto-ubiquitination, rather than ubiquitination by some other E3. However, because th6 DIAP1 is a mutant protein in which the RING structure has been disrupted, we cannot rule out the possibility that it is simply unable to interact with a second E3 that mediates Hiddependent stimulation of DIAP1 ubiquitination. However, the failure of th6 DIAP1 levels to change in the presence of Hid argues against the possibility that the Hid-stimulated reduction of unmodified DIAP1 (Fig. 6c,d ) occurs by activation a DIAP1-cleaving protease. This point is also suggested, but with wild-type DIAP1, by the results of ubiquitination assays containing wild-type DIAP1, glutathione S transferase (GST) and Hid in embryo extract, Figure 6 Hid stimulates DIAP1 polyubiquitination. Western blots are shown of wild-type DIAP1 and th6 DIAP1in combination with other factors, probed with an anti-DIAP1 antibody. a, DIAP1 underwent time-dependent polyubiquitination in a reaction consisting of purified E1, E2, DIAP1 and ubiquitin. Polyubiquitinated species of DIAP1 were upshifted, as indicated (Diap1-Ub(n)) b, Wild-type DIAP1 was also polyubiquitinated in Drosophila embryo extracts supplemented with the proteosome inhibitor lactacystin (compare 0 min with 30 min), but th6 DIAP1 was not. c, DIAP1 underwent time-dependent polyubiquitination in the presence of embryo extract, lactacystin, and GST as a control. Substitution of Rpr or Grim for GST in this assay did not appreciably stimulate DIAP1 polyubiquitination further. d, In contrast, substitution of Hid for GST resulted in a strong stimulation of DIAP1 polyubiquitination, as indicated by the increased abundance of high molecular weight DIAP1-immunoreactive species at 10 and 30 min. e, Polyubiquitination of th6 DIAP1 in embryo extracts was not stimulated by Hid, nor was degradation of the unmodified DIAP1. f, DIAP1 underwent time-dependent mono-ubiquitination (DIAP1-Ubm) when embryo extracts containing GST were supplemented with methyl-ubiquitin. Substitution of Hid for GST in a similar reaction resulted in a stimulation of DIAP1 mono-ubiquitination. Hid did not stimulate a dramatic loss of unmodified DIAP1, arguing against the possibility that Hid stimulates the degradation of wild-type, unmodified DIAP1. g, Quantification of the time-dependent loss of unmodified DIAP1 in experiments similar to those shown in c and d for wild-type DIAP1. Time-zero was normalized to 100%. Hid promotes roughly a fivefold decrease in the levels of unmodified DIAP1 after 30 min of incubation (n = 5 independent experiments). Rpr and Grim did not appreciably stimulate loss of unmodified DIAP1 in comparison to assays that contained GST (n = 3 independent experiments).
in which methylated ubiquitin was added to the reaction. Methylated ubiquitin is unable to form polyubiquitin chains with substrate-bound ubiquitin 33 . Thus, substrate proteins can only be mono-ubiquitinated, making it easier to analyse protein fate by SDS-polyacrylamide gel electrophoresis (PAGE). DIAP1 in the presence of embryo extract, GST, and methylated ubiquitin was mono-ubiquitinated in a time-dependent manner. As expected, substitution of Hid for GST stimulated DIAP1 mono-ubiquitination. However, it did not result in a large decrease in the levels of the unmodified form, which might suggest proteolytic cleavage (Fig.  6f) . We observed a time-dependent loss of unmodified DIAP1 in all assays, reflecting its movement into higher molecular weight ubiquitinated forms (Fig. 6c,d,g ). Hid, but not GST, Rpr or Grim, stimulated this loss greater than fivefold after 30 min of incubation (Fig. 6g) .
Together, the above observations (as well as observations presented in Fig. 7) argue that Hid promotes DIAP1 ubiquitination, perhaps by stimulating auto-ubiquitination, and that this subsequently results in its degradation by the proteosome. Loss of DIAP1, as shown in the Fig. 1 for the DIAP1 mutant embryos, is sufficient to promote effector caspase activation. Thus, Hid combines two anti-DIAP1 pro-apoptotic functions: it directly inhibits the caspase-inhibiting activity of DIAP1 and promotes its degradation. Both of these activities should contribute to the observed increase in caspase activation in Hid-expressing cells (Figs 2, and 5) .
Grim, but not Hid, can generally suppress translation. Rpr and Grim also promote the disappearance of DIAP1 in vivo. However, they did not appreciably stimulate DIAP1 polyubiquitination in a Drosophila extract. This lack of activity may reflect the adoption of unphysiological conformations by Rpr and Grim, or limitations of the assay used. For example, factors necessary for the ability of Rpr and Grim to stimulate DIAP1 ubiquitination might not be functional in the extract as prepared. This possibility is reflected by the observation that Hid did not significantly promote DIAP1 polyubiquitination in a purified reaction consisting of E1, E2, DIAP1 and ubiquitin, suggesting that other factors may be required (S.J.Y. and B.A.H., unpublished observations). Alternatively, Rpr and Grim might regulate a distinct step of ubiquitination stimulation that is not detected in our assay. For example, given the robust ubiquitination of DIAP1 in the embryo extract used, it is possible that proteins that stimulate ubiquitination by inhibiting inhibitors of ubiquitination would not be recognized as such. Notwithstanding these possibilities, several points can be made: Hid did function in the Drosophila embryo extract system. In addition, in vivo Rpr and Grim, but not Hid, promoted the loss of th6 DIAP1, which is not functional as a ubiquitin ligase. Finally, although heterozygosity for th6 resulted in a strong suppression of Hid-dependent cell death in the fly eye, consistent with a model in which Hid promotes apoptosis by stimulating DIAP1 degradation, heterozygosity for th6 did not result in suppression of Rpr-or Grim-dependent cell death 13 . Together, these observations argue that Rpr and Grim are able to Figure 7 Hid induces a post-translational loss of DIAP1, whereas Grim causes a general suppression of translation. Wild-type DIAP1, th6 DIAP1 or luciferase were translated in a reticulocyte lysate system in the presence of 35 Smethionine, either alone or in combination with Hid or Grim. Hid or Grim were also added to some reactions after translation termination. The products were visualized after SDS-PAGE. a, Hid suppressed the appearance of wild-type DIAP1 (DIAP1 wt ), but not th6 DIAP1 or luciferase, when added cotranslationally. In contrast, cotranslational addition of Grim resulted in a decrease in the appearance of all three proteins. b, Translation reactions for wild-type DIAP1, th6 DIAP1 or luciferase were either left untreated, or incubated with Hid or Grim. Post-translational addition of Hid resulted in a decrease in the levels of wild-type DIAP1, but not of th6 DIAP1 or luciferase. Post-translational addition of Grim had no effect on the stability of any of the three proteins. c, In vitro translated versions of wild-type DIAP1, th6 DIAP1 or luciferase were assayed for their ability to bind to Hid-bound beads. Wild-type DIAP1 and th6 DIAP1 bound equally well to Hid beads, but did not bind to GST-beads. d, Drosophila translation extract supplemented with 35 S-methionine and either GST, Grim or Hid. Endogenous mRNAs drive the synthesis of multiple proteins. Grim, but not Hid, suppresses protein synthesis in this system. regulate DIAP1 levels through post-transcriptional mechanisms distinct from those used by Hid. Inhibition of protein synthesis is often sufficient to induce apoptosis (see ref. 34 and references therein). To determine if Grim suppressed translation, we in vitro translated 35 S-labelled versions of wild-type DIAP1, th6 DIAP1 or luciferase, alone or in the presence of recombinant Hid or Grim, in a rabbit reticulocyte system (Fig. 7a) . The appearance of wild-type DIAP1 was largely eliminated by cotranslational addition of Hid (Fig. 7a) , while the appearance of th6 DIAP1 or luciferase was largely unaffected. In contrast, cotranslational incubation of translation reactions with Grim resulted in a large decrease in the appearance of all three proteins (Fig. 7a) . Post-translational addition of Hid resulted in a decrease in the levels of wild-type DIAP1, but not of th6 DIAP1 or luciferase, consistent with the idea that Hid promotes DIAP1 ubiquitination and degradation (Fig. 7b) . Hid was, however, still able to bind th6 DIAP1 (Fig. 7c) . In contrast, post-translational addition of Grim had no effect on the abundance of wild-type DIAP1, th6 DIAP1 or luciferase, suggesting that Grim was suppressing translation directly. We tested this hypothesis further in a Drosophila embryo extract translation system derived from 0-2-h-old embryos 35 . Translation reactions were carried out in the presence of GST, Hid or Grim, and 35 S-labelled translation products derived from endogenous mRNAs were visualized after SDS-PAGE. In common with our observations in the reticulocyte lysate system, the presence of Grim, but not Hid, resulted in a significant decrease in total protein translation (Fig.  7d) . The mechanism underlying this phenomenon is unlikely to involve caspase cleavage of translation factors 36 , as Grim suppressed translation in reticulocyte lysates and Drosophila extracts in the presence of the potent caspase inhibitor zVAD. Finally, if Rpr and Grim promote apoptosis by inhibiting translation, then inhibition of protein synthesis in Drosophila might be expected to promote apoptosis. Consistent with this hypothesis, S2 cells exposed to cycloheximide died rapidly, adopting an apoptotic morphology (see Supplementary Information, Fig. S1 ).
These results, in conjunction with those of Holley et al. using Rpr (see note added in proof), argue that Grim and Rpr promote a general suppression of translation. Our experiments involved overexpression in vivo and the use of recombinant protein in extracts. Thus, we cannot rule out the possibility that Grim-and/or Rprdependent effects on translation reflect interactions with cellular components that would not normally occur. However, the hypothesis is imminently testable, as translational control targets can be identified. In addition, it will ultimately be important to demonstrate that endogenous levels of Rpr or Grim in identified cells fated to die, in the presence of caspase inhibitors, are sufficient to promote translational suppression, and that elimination of these genes results in a loss of translational suppression in these same cells.
Discussion
IAPs directly inhibit active caspases, and in addition, IAPs can promote their ubiquitination and degradation. Thus, IAPs constitute a last line of defence against death-inducing caspase activity. The importance of this function is made clear from our characterization of the DIAP1 loss-of-function phenotype. Loss of DIAP1 is sufficient to promote effector caspase activation in most, if not all, cells in the early embryo, and this activity is necessary for apoptotic nuclease activation. Thus, regulation of the relative levels of IAPs, and the caspases they inhibit, is one mechanism by which cells can control entry into apoptosis. Here, we describe two mechanisms through which DIAP1 ubiquitination regulates this balance. Hid stimulates DIAP1 ubiquitination and degradation directly. Grim (this work) and Rpr (see note added in proof) can promote a general suppression of protein translation. DIAP1 has a short half-life (about 40 min) because of its activity as a ubiquitin-protein ligase. But the half-life of an important target, the apical caspase Dronc, is much longer (about 3 h; see Supplementary Information Fig. S1 ).
Thus, all other things being equal, inhibition of protein synthesis will result in an imbalance in the relative levels of apoptosis inducers and inhibitors such as IAPs. In some cases, such as the early fly embryo, this alone will be sufficient to promote unrestrained caspase activation, whereas in other cases it may constitute a mechanism for sensitizing cells to other caspase-activating pathways. As mechanistic insight is gained into the workings of this pathway, it will be interesting to see if translational inhibition can be harnessed as a therapeutic tool. Finally, mutations that alter the RING domain stabilize IAPs (this work, refs 9,40) . If these proteins retain the ability to inhibit caspases, they will function as better death inhibitors, thus inappropriately promoting cell survival. However, such mutated IAPs will also be unable to promote the ubiquitination and degradation of bound apoptosis inducers, such as caspases, and perhaps proteins such as Rpr, Hid, Grim or their mammalian counterparts, thus promoting cell death. Which outcome dominates is likely to be dependent on cell-type and the context. In either case, it will be interesting to see if C-terminal mutations in IAPs are associated with dysregulation of cell death in human disease. 
Methods

Fly Strains
The following fly stocks were used: Oregon R. UAS::p35 (on third). UAS::p35 UAS::hid (onX). UAS::grim/UAS::grim (on2),UAS::p35/UAS::p35 (on3). UAS::rpr/UAS::rpr (on2); UAS::p35/UAS::p35 (on3). en::Gal4/en::Gal4 (ref. 
Antibody generation
Anti-active Drice-specific antibodies were raised in rabbits using a synthetic octapeptide, corresponding to residues surrounding the cleavage site of Drice (QRSQTETD) conjugated with Keyhole Limpet Haemocyanin (KLH) as the immunogen (Covance Research Products Incorporated, Richmond, CA). Active-Drice-specific antibodies were purified by sequential protein affinity purification methods. Antisera were first applied to a column bound with full-length inactive Drice (DriceC211A) to eliminate antibodies reactive to uncleaved Drice. The flow-through was applied to a Drice p21 subunit (residues 81-230) affinity column. Bound proteins were eluted using 100 mM glycine at pH 2.5. These antibodies detect the large fragment of active Drice, but do not recognize full-length Drice or the closely related caspase DCP-1 (J.R.H. and B.A.H, unpublished observations). Anti-Hid antibodies were produced in rabbits using full-length Hid with a C-terminal 6×His tag as the immunogen (Covance Research Products Inc). Anti-Dronc antibodies were produced in rabbits using a C-terminally 6×His-tagged version of the Dronc p20 subunit as the immunogen. An anti-DIAP1 monoclonal antibody was generated in mouse using a GST-DIAP1 fusion protein as the immunogen.
Fixation, immunolabelling and in situ hybridization of embryos
Embryos were collected and staged as described 19 . For immunolabelling, embryos were fixed with modified Stefanini's Fixative 38 . For in situ hybridization, embryos were fixed with 8% paraformaldehyde in PBS. Immunolabelling and TUNEL assays were performed essentially as described 19 . In situ Preparation of recombinant Drosophila proteins DIAP1-D20E was prepared as described previously 19 from GST-TEV-DIAP1-D20E before TEV cleavage. pET23a-Hid-6×His and pET23a-Grim-6×His were expressed in Escherichia coli BL21(DE3) pLysS and purified under denaturing conditions. The pellet was dissolved in buffer S (6 M Guanidine-HCl, 100 mM NaH 2 PO 4 , 10 mM Tris-HCl at pH 8.0, 10 mM β-mercaptoethanol and 500 mM sodium chloride) before sonication and centrifugation. The supernatant was mixed with nickel-agarose (Qiagen, Valencia, CA) at room temperature for 1 h. The resin was washed with buffer WA (8 M urea, 100 mM NaH 2 PO 4, 10 mM Tris-HCl at pH 8.0, 10 mM β-mercaptoethanol and 500 mM sodium chloride) four times and subsequently washed with buffer WB (buffer WA at pH 6.3). The protein was eluted with buffer EL (buffer WA at pH 4.5), and each protein was renatured by stepwise dialysis from 8-0 M urea buffer. Proteins were then dialysed into buffer UD (20 mM Tris-HCl at pH 7.5, 100 mM sodium chloride, 1 mM dithiothreitol (DTT) and 10% Glycerol). A full-length Rpr peptide was provided by S. Kornbluth and introduced into buffer UD before use.
Embryo extract preparation and ubiquitination assays
Drosophila embryo extract was made at 25 ο C from 2-5-h-old embryos. Embryos were dechorionated with 50% bleach, rinsed, suspended in an equal volume of buffer EX (20 mM Tris-HCl at pH 7.5, 100 mM sodium chloride, 5 mM ATP, 2.5 mM magnesium chloride, 1 mM DTT and 0.25 M Sucrose) and homogenized. The supernatant was collected after centrifugation at 12,000g. The extract was adjusted to 10 µg µl −1 with buffer EX. For ubiquitination assays with Drosophila embryo extract, GST, Hid, Rpr or Grim were pre-incubated with 1 µl of embryo extract at room temperature for 20 min. Subsequently, DIAP1-D20E and His-ubiquitin (2 µg total; Calbiochem, San Diego, CA) were added. The reaction was carried out in a final volume of 15 µl of buffer UR (25 mM Tris-HCl at pH 7.5, 0.5 mM DTT, 2 mM ATP and 5 mM magnesium chloride). GST, Hid, Rpr or Grim were present at final concentrations of 1 µM, and DIAP1 at 0.5 µM. The reaction was carried out at 37 ο C for various times. Reactions were stopped by addition of SDS sample buffer. DIAP1 was visualized using a mouse anti-DIAP1 antibody after SDS-PAGE and western blotting. NIH image software was used to quantify DIAP1-D20E band intensity. Ubiquitination reactions with purified proteins utilized E1 and E2 (GST-UbcH5A) purchased from Affiniti Research products (Nottingham, UK). DIAP1 (0.5µM, 400 ng) was incubated with 100 ng of E1 and 300 ng of E2, and 2 µg of His-ubiquitin in buffer UR. Products were characterized as above.
In vitro translation reactions
Rabbit reticulocyte lysate translation reactions were carried out according to the manufacturer's instructions (Promega) . Recombinant Hid and Grim were used at a final concentration of 7 nM and 70 nM, respectively. For cotranslational reactions, proteins were pre-incubated with reticulocyte lysate at 30 ο C for 10 min before addition of RNA template. For post-translational assays, RNA templates were translated at 30 ο C for 1 h. Reactions were terminated by a 5-min incubation with 0.8 µg µl −1 RNase A (Qiagen), before addition of recombinant proteins. Translation products were resolved by 12% SDS-PAGE. Drosophila extract translation reactions were carried out as described previously 35 , in the presence of recombinant GST, Hid or Grim (80 ng). Proteins were pre-incubated with embryo extract (provided by P. Zamore) at 25 ο C for 10 min before addition of amino acid mix and 35 S-methionine. All translation reaction reactions included the general caspase inhibitor zVAD (100µM).
Hid binding assay
Reticulocyte-lysate-translated DIAP1, th6 DIAP1 or luciferase were bound to 10 µl of Affigel resin (Biorad, Hercules, CA) prebound with Hid or GST in binding buffer (25 mM HEPES at pH 7.5, 250 mM sodium chloride, 20 mM β-mercaptoethanol, 0.1% Triton-X100, containing the Complete EDTA-free protease inhibitor (Boehringer Mannheim, Indianapolis, IN). Samples were processed for SDS-PAGE analysis after multiple washes with binding buffer.
DIAP1 and Dronc half-life measurements and cell killing assay
6 × 10 6 S2 cells were seeded in TC-100 media containing 10% foetal bovine serum (Invitrogen, Carlsbad, CA) overnight. The next day, cycloheximide was added at 100 µg ml −1 . Carrier (ethanol) was added alone to a separate well as a control. Cells were then harvested at 20-min intervals up to 140 min, centrifuged at 14,000g for 2 min before lysis in SDS-PAGE loading buffer. Lysate was run on SDS-PAGE gels and immunoblotted. Blots were analysed for DIAP1 using monoclonal anti-DIAP1, anti-mouse secondary antibody and SuperSignal chemiluminescent substrate (Pierce, Rockford, IL). Similarly, blots for Dronc were developed using rabbit anti-Dronc and the anti-rabbit secondary antibody. After measuring band intensity by densitometry, the results were tabulated and half-life was determined by best-fit analysis. To measure cell killing in response to cycloheximide, S2 cells were treated with 100 µg ml 
